ArticlePeriodicum biologorum2012
Sleep and stroke.
Article in Periodicum biologorum, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 7 citations in OpenAlex.
- Stroke in young adults, stroke types and risk factors: a case control study.BMC neurology · 2022Article
- Distribution of Stroke Risk Factors in Eastern Croatia.Acta clinica Croatica · 2018Article
- Sex differences in stroke: a socioeconomic perspective.Clinical interventions in agingArticle
- Role of Obstructive Sleep Apnea in Cognitive Impairment.International journal of head and neck surgeryArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
Obstructive Sleep-Disordered Breathing (OSDB) is an under-recognized risk factor for stroke. OSDB is associated with traditional vascular risk factors such as hypertension, obesity, and diabetes, and can influence the risk for stroke through direct and indirect mechanisms. Untreated OSDB may also influence rehabilitation efforts and functional outcome following a stroke, as well as the risk for stroke recurrence. Stroke risk is greatly reduced if the OSDB is adequately treated. Conversely, OSDB may be exacerbated or caused by stroke. Increasing awareness and improving screening for OSDB is paramount in the primary and secondary prevention of stroke, and in improving stroke outcomes. The following review article is intended to highlight the current basics of epidemiology, clinical characteristics, pathophysiology, diagnosis, and treatment of OSDB in relation to stroke.
Indexed as
Identifiers
30853719PMC6405213W1571491816What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.